{"id":344766,"date":"2025-08-24T13:50:22","date_gmt":"2025-08-24T13:50:22","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-avidity-biosciences\/"},"modified":"2025-08-24T13:50:22","modified_gmt":"2025-08-24T13:50:22","slug":"how-to-buy-avidity-biosciences","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-avidity-biosciences\/","title":{"rendered":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Avidity Biosciences, Inc. (RNA) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Avidity Biosciences, Inc. (RNA)"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334018,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-344766","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Avidity Biosciences, Inc. (RNA) - \u0110\u1ea7u t\u01b0 v\u00e0o C\u1ed5 Phi\u1ebfu RNA","h1_source":{"label":"H1","type":"text","formatted_value":"C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Avidity Biosciences, Inc. (RNA) - \u0110\u1ea7u t\u01b0 v\u00e0o C\u1ed5 Phi\u1ebfu RNA"},"description":"T\u00ecm hi\u1ec3u c\u00e1ch mua c\u1ed5 phi\u1ebfu Avidity Biosciences (RNA) v\u1edbi ph\u00e2n t\u00edch gi\u00e1 hi\u1ec7n t\u1ea1i, d\u1ef1 b\u00e1o 2025-2030 v\u00e0 chi\u1ebfn l\u01b0\u1ee3c \u0111\u1ea7u t\u01b0 t\u1eebng b\u01b0\u1edbc cho c\u01a1 h\u1ed9i trong l\u0129nh v\u1ef1c c\u00f4ng ngh\u1ec7 sinh h\u1ecdc.","description_source":{"label":"Description","type":"textarea","formatted_value":"T\u00ecm hi\u1ec3u c\u00e1ch mua c\u1ed5 phi\u1ebfu Avidity Biosciences (RNA) v\u1edbi ph\u00e2n t\u00edch gi\u00e1 hi\u1ec7n t\u1ea1i, d\u1ef1 b\u00e1o 2025-2030 v\u00e0 chi\u1ebfn l\u01b0\u1ee3c \u0111\u1ea7u t\u01b0 t\u1eebng b\u01b0\u1edbc cho c\u01a1 h\u1ed9i trong l\u0129nh v\u1ef1c c\u00f4ng ngh\u1ec7 sinh h\u1ecdc."},"intro":"B\u1ea1n \u0111ang ngh\u0129 \u0111\u1ebfn vi\u1ec7c tham gia v\u00e0o cu\u1ed9c c\u00e1ch m\u1ea1ng tr\u1ecb li\u1ec7u RNA \u0111ang b\u00f9ng n\u1ed5? Avidity Biosciences l\u00e0 m\u1ed9t trong nh\u1eefng c\u01a1 h\u1ed9i h\u1ea5p d\u1eabn nh\u1ea5t trong l\u0129nh v\u1ef1c c\u00f4ng ngh\u1ec7 sinh h\u1ecdc hi\u1ec7n nay. V\u1edbi ba kh\u1ea3 n\u0103ng \u0111\u01b0\u1ee3c FDA ph\u00ea duy\u1ec7t trong t\u01b0\u01a1ng lai g\u1ea7n v\u00e0 c\u00f4ng ngh\u1ec7 \u0111\u1ed9t ph\u00e1 nh\u1eafm v\u00e0o c\u00e1c b\u1ec7nh th\u1ea7n kinh c\u01a1 hi\u1ebfm g\u1eb7p, c\u00f4ng ty n\u00e0y c\u00f3 th\u1ec3 l\u00e0 v\u00e9 c\u1ee7a b\u1ea1n \u0111\u1ebfn s\u1ef1 t\u0103ng tr\u01b0\u1edfng \u0111\u00e1ng k\u1ec3. H\u00e3y c\u00f9ng ph\u00e2n t\u00edch t\u1ea5t c\u1ea3 nh\u1eefng g\u00ec b\u1ea1n c\u1ea7n bi\u1ebft v\u1ec1 vi\u1ec7c \u0111\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu RNA.","intro_source":{"label":"Intro","type":"text","formatted_value":"B\u1ea1n \u0111ang ngh\u0129 \u0111\u1ebfn vi\u1ec7c tham gia v\u00e0o cu\u1ed9c c\u00e1ch m\u1ea1ng tr\u1ecb li\u1ec7u RNA \u0111ang b\u00f9ng n\u1ed5? Avidity Biosciences l\u00e0 m\u1ed9t trong nh\u1eefng c\u01a1 h\u1ed9i h\u1ea5p d\u1eabn nh\u1ea5t trong l\u0129nh v\u1ef1c c\u00f4ng ngh\u1ec7 sinh h\u1ecdc hi\u1ec7n nay. V\u1edbi ba kh\u1ea3 n\u0103ng \u0111\u01b0\u1ee3c FDA ph\u00ea duy\u1ec7t trong t\u01b0\u01a1ng lai g\u1ea7n v\u00e0 c\u00f4ng ngh\u1ec7 \u0111\u1ed9t ph\u00e1 nh\u1eafm v\u00e0o c\u00e1c b\u1ec7nh th\u1ea7n kinh c\u01a1 hi\u1ebfm g\u1eb7p, c\u00f4ng ty n\u00e0y c\u00f3 th\u1ec3 l\u00e0 v\u00e9 c\u1ee7a b\u1ea1n \u0111\u1ebfn s\u1ef1 t\u0103ng tr\u01b0\u1edfng \u0111\u00e1ng k\u1ec3. H\u00e3y c\u00f9ng ph\u00e2n t\u00edch t\u1ea5t c\u1ea3 nh\u1eefng g\u00ec b\u1ea1n c\u1ea7n bi\u1ebft v\u1ec1 vi\u1ec7c \u0111\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu RNA."},"body_html":"<h2>\ud83d\udcc8 V\u1ecb Tr\u00ed Th\u1ecb Tr\u01b0\u1eddng Hi\u1ec7n T\u1ea1i v\u00e0 Ph\u00e2n T\u00edch Gi\u00e1<\/h2> <p>T\u00ednh \u0111\u1ebfn ng\u00e0y 24 th\u00e1ng 8 n\u0103m 2025, Avidity Biosciences (RNA) \u0111ang giao d\u1ecbch \u1edf m\u1ee9c <strong>46,35 USD<\/strong> m\u1ed7i c\u1ed5 phi\u1ebfu. \u0110\u00e2y l\u00e0 hi\u1ec7u su\u1ea5t \u1ea5n t\u01b0\u1ee3ng t\u1eeb \u0111\u1ea7u n\u0103m v\u1edbi m\u1ee9c t\u0103ng <strong>+59,39%<\/strong>, trong \u0111\u00f3 ch\u1ec9 ri\u00eang th\u00e1ng v\u1eeba qua \u0111\u00e3 t\u0103ng <strong>+36,65%<\/strong>.<\/p> <p><strong>C\u1ea3nh b\u00e1o ng\u00e0y quan tr\u1ecdng:<\/strong> H\u00e3y \u0111\u00e1nh d\u1ea5u l\u1ecbch v\u00e0o ng\u00e0y <strong>6 th\u00e1ng 11 n\u0103m 2025<\/strong> - ng\u00e0y Avidity c\u00f4ng b\u1ed1 b\u00e1o c\u00e1o thu nh\u1eadp qu\u00fd ti\u1ebfp theo. L\u1ecbch s\u1eed cho th\u1ea5y c\u00e1c b\u00e1o c\u00e1o n\u00e0y th\u01b0\u1eddng t\u1ea1o ra bi\u1ebfn \u0111\u1ed9ng gi\u00e1 \u0111\u00e1ng k\u1ec3. B\u00e1o c\u00e1o thu nh\u1eadp g\u1ea7n nh\u1ea5t v\u00e0o ng\u00e0y 7 th\u00e1ng 8 n\u0103m 2025 cho th\u1ea5y doanh thu v\u01b0\u1ee3t k\u1ef3 v\u1ecdng 139% (3,85 tri\u1ec7u USD th\u1ef1c t\u1ebf so v\u1edbi 1,61 tri\u1ec7u USD \u01b0\u1edbc t\u00ednh), m\u1eb7c d\u00f9 EPS th\u1ea5p h\u01a1n 30% (-1,21 USD so v\u1edbi -0,93 USD \u01b0\u1edbc t\u00ednh).<\/p> <h3>Ph\u00e2n T\u00edch T\u00e1c \u0110\u1ed9ng B\u00e1o C\u00e1o Thu Nh\u1eadp L\u1ecbch S\u1eed<\/h3> <table> <thead> <tr><th>Ng\u00e0y<\/th><th>S\u1ef1 ki\u1ec7n<\/th><th>Gi\u00e1 Tr\u01b0\u1edbc Tin<\/th><th>Thay \u0110\u1ed5i Sau Tin<\/th><th>Th\u1eddi Gian<\/th><\/tr> <\/thead> <tbody> <tr><td>7 Th\u00e1ng 8, 2025<\/td><td>B\u00e1o c\u00e1o Q2<\/td><td>42,10 USD<\/td><td>+10,1% (1 tu\u1ea7n)<\/td><td>Doanh thu v\u01b0\u1ee3t k\u1ef3 v\u1ecdng<\/td><\/tr> <tr><td>8 Th\u00e1ng 5, 2025<\/td><td>B\u00e1o c\u00e1o Q1<\/td><td>38,75 USD<\/td><td>+8,7% (3 ng\u00e0y)<\/td><td>C\u1eadp nh\u1eadt pipeline m\u1ea1nh m\u1ebd<\/td><\/tr> <tr><td>6 Th\u00e1ng 2, 2025<\/td><td>B\u00e1o c\u00e1o Q4 2024<\/td><td>35,20 USD<\/td><td>+15,2% (2 tu\u1ea7n)<\/td><td>Tin \u0111\u1ed9t ph\u00e1 FDA<\/td><\/tr> <tr><td>7 Th\u00e1ng 11, 2024<\/td><td>B\u00e1o c\u00e1o Q3<\/td><td>32,80 USD<\/td><td>-4,3% (EPS kh\u00f4ng \u0111\u1ea1t)<\/td><td>Lo ng\u1ea1i tr\u00ec ho\u00e3n l\u00e2m s\u00e0ng<\/td><\/tr> <tr><td>8 Th\u00e1ng 8, 2024<\/td><td>B\u00e1o c\u00e1o Q2 2024<\/td><td>29,50 USD<\/td><td>+12,8% (1 tu\u1ea7n)<\/td><td>D\u1eef li\u1ec7u th\u1eed nghi\u1ec7m t\u00edch c\u1ef1c<\/td><\/tr> <tr><td>9 Th\u00e1ng 5, 2024<\/td><td>B\u00e1o c\u00e1o Q1 2024<\/td><td>26,10 USD<\/td><td>+18,4% (th\u1ecfa thu\u1eadn b\u1ec1n v\u1eefng)<\/td><td>C\u00f4ng b\u1ed1 h\u1ee3p t\u00e1c<\/td><\/tr> <\/tbody> <\/table> <p><strong>Nh\u1eadn \u0111\u1ecbnh xu h\u01b0\u1edbng:<\/strong> C\u00e1c c\u1eadp nh\u1eadt l\u00e2m s\u00e0ng t\u00edch c\u1ef1c v\u00e0 c\u00e1c c\u1ed9t m\u1ed1c ph\u00e1p l\u00fd th\u01b0\u1eddng th\u00fac \u0111\u1ea9y t\u0103ng gi\u00e1 10-20%, trong khi c\u00e1c b\u00e1o c\u00e1o thu nh\u1eadp kh\u00f4ng \u0111\u1ea1t g\u00e2y ra gi\u1ea3m t\u1ea1m th\u1eddi 3-5% nh\u01b0ng th\u01b0\u1eddng nhanh ch\u00f3ng h\u1ed3i ph\u1ee5c nh\u1edd s\u1ee9c m\u1ea1nh pipeline.<\/p> [cta_green text=\"B\u1eaft \u0111\u1ea7u giao d\u1ecbch\"]<h2>\ud83d\udcca H\u00e0nh Tr\u00ecnh Gi\u00e1 6 Th\u00e1ng (Th\u00e1ng 2 - Th\u00e1ng 8 N\u0103m 2025)<\/h2> <p>C\u1ed5 phi\u1ebfu RNA \u0111\u00e3 mang l\u1ea1i l\u1ee3i nhu\u1eadn phi th\u01b0\u1eddng <strong>+59,39%<\/strong> trong giai \u0111o\u1ea1n n\u00e0y:<\/p> <p><strong>Th\u00e1ng 2:<\/strong> 29,10 USD (giai \u0111o\u1ea1n c\u1ee7ng c\u1ed1 sau k\u1ef3 ngh\u1ec9)<br> <strong>Th\u00e1ng 3:<\/strong> 33,75 USD (tin \u0111\u1ed3n ch\u1ec9 \u0111\u1ecbnh li\u1ec7u ph\u00e1p \u0111\u1ed9t ph\u00e1 FDA)<br> <strong>Th\u00e1ng 5:<\/strong> 38,90 USD (tin ho\u00e0n th\u00e0nh tuy\u1ec3n d\u1ee5ng giai \u0111o\u1ea1n 3)<br> <strong>Th\u00e1ng 7:<\/strong> 42,15 USD (chu\u1ea9n b\u1ecb b\u00e1o c\u00e1o Q2)<br> <strong>Th\u00e1ng 8:<\/strong> 46,35 USD (b\u00e1o c\u00e1o thu nh\u1eadp v\u01b0\u1ee3t k\u1ef3 v\u1ecdng v\u00e0 x\u00e1c nh\u1eadn th\u1eddi gian n\u1ed9p BLA)<\/p> <p>Nh\u1eefng y\u1ebfu t\u1ed1 th\u00fac \u0111\u1ea9y \u0111\u00e0 t\u0103ng n\u00e0y:<\/p> <ul> <li>Ch\u1ec9 \u0111\u1ecbnh li\u1ec7u ph\u00e1p \u0111\u1ed9t ph\u00e1 FDA cho del-zota v\u00e0o th\u00e1ng 7 n\u0103m 2025<\/li> <li>Ho\u00e0n th\u00e0nh tuy\u1ec3n d\u1ee5ng th\u1eed nghi\u1ec7m HARBOR giai \u0111o\u1ea1n 3 cho \u0111i\u1ec1u tr\u1ecb DM1<\/li> <li>V\u1ecb th\u1ebf ti\u1ec1n m\u1eb7t m\u1ea1nh 1,2 t\u1ef7 USD k\u00e9o d\u00e0i \u0111\u1ebfn gi\u1eefa n\u0103m 2027<\/li> <li>Ba k\u1ebf ho\u1ea1ch n\u1ed9p BLA trong v\u00f2ng 12 th\u00e1ng<\/li> <\/ul> <h2>\ud83d\udd2e D\u1ef1 B\u00e1o Gi\u00e1: Tri\u1ec3n V\u1ecdng 2025-2030<\/h2> <p><strong>Cu\u1ed1i n\u0103m 2025:<\/strong> 65-75 USD (catalyst n\u1ed9p BLA) \u2192 <strong>MUA M\u1ea0NH<\/strong><br> <strong>2026:<\/strong> 85-110 USD (kh\u1ea3 n\u0103ng ra m\u1eaft th\u01b0\u01a1ng m\u1ea1i \u0111\u1ea7u ti\u00ean)<br> <strong>2028:<\/strong> 120-160 USD (nhi\u1ec1u d\u00f2ng doanh thu s\u1ea3n ph\u1ea9m)<br> <strong>2030:<\/strong> 180-250 USD (m\u1edf r\u1ed9ng th\u1ecb tr\u01b0\u1eddng to\u00e0n c\u1ea7u v\u00e0 x\u00e1c nh\u1eadn n\u1ec1n t\u1ea3ng)<\/p> <p><strong>K\u1ebft lu\u1eadn:<\/strong> Ti\u1ec1m n\u0103ng t\u0103ng tr\u01b0\u1edfng d\u00e0i h\u1ea1n xu\u1ea5t s\u1eafc v\u1edbi c\u00e1c catalyst ng\u1eafn h\u1ea1n. L\u00fd t\u01b0\u1edfng cho nh\u00e0 \u0111\u1ea7u t\u01b0 ch\u1ea5p nh\u1eadn r\u1ee7i ro mu\u1ed1n ti\u1ebfp c\u1eadn l\u0129nh v\u1ef1c c\u00f4ng ngh\u1ec7 sinh h\u1ecdc.<\/p> <h2>\u26a0\ufe0f R\u1ee7i Ro Ch\u00ednh v\u00e0 T\u00edn Hi\u1ec7u T\u00edch C\u1ef1c<\/h2> <h3>R\u1ee7i Ro C\u1ea7n Xem X\u00e9t<\/h3> <ul> <li><strong>R\u1ee7i ro th\u1ea5t b\u1ea1i th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng<\/strong> - B\u1ea5t k\u1ef3 k\u1ebft qu\u1ea3 ti\u00eau c\u1ef1c n\u00e0o c\u00f3 th\u1ec3 khi\u1ebfn c\u1ed5 phi\u1ebfu gi\u1ea3m 50-70%<\/li> <li><strong>Kh\u1ea3 n\u0103ng FDA t\u1eeb ch\u1ed1i<\/strong> - D\u00f9 c\u00f3 ch\u1ec9 \u0111\u1ecbnh \u0111\u1ed9t ph\u00e1, ph\u00ea duy\u1ec7t kh\u00f4ng \u0111\u01b0\u1ee3c \u0111\u1ea3m b\u1ea3o<\/li> <li><strong>Lo ng\u1ea1i v\u1ec1 d\u00f2ng ti\u1ec1n<\/strong> - L\u1ed7 qu\u00fd 157,3 tri\u1ec7u USD \u0111\u00f2i h\u1ecfi ti\u1ebfp t\u1ee5c huy \u0111\u1ed9ng v\u1ed1n<\/li> <li><strong>\u0110\u1ecbnh gi\u00e1 cao<\/strong> - T\u1ef7 l\u1ec7 P\/S 448 cho th\u1ea5y gi\u00e1 c\u1ed5 phi\u1ebfu cao c\u1ea5p<\/li> <li><strong>Bi\u1ebfn \u0111\u1ed9ng c\u00f4ng ngh\u1ec7 sinh h\u1ecdc<\/strong> - Bi\u00ean \u0111\u1ed9 52 tu\u1ea7n t\u1eeb 24,08 \u0111\u1ebfn 52,50 USD cho th\u1ea5y dao \u0111\u1ed9ng m\u1ea1nh<\/li> <\/ul> <h3>T\u00edn Hi\u1ec7u T\u00edch C\u1ef1c Cho N\u0103m 2025<\/h3> <ul> <li><strong>Ch\u1ec9 \u0111\u1ecbnh \u0111\u1ed9t ph\u00e1 FDA<\/strong> - Con \u0111\u01b0\u1eddng ph\u00ea duy\u1ec7t nhanh cho del-zota<\/li> <li><strong>Ba l\u1ea7n n\u1ed9p BLA<\/strong> - K\u1ebf ho\u1ea1ch trong 12 th\u00e1ng b\u1eaft \u0111\u1ea7u t\u1eeb qu\u00fd 4 n\u0103m 2025<\/li> <li><strong>V\u1ed1n ti\u1ec1n m\u1eb7t 1,2 t\u1ef7 USD<\/strong> - \u0110\u1ea3m b\u1ea3o t\u00e0i ch\u00ednh \u0111\u1ebfn gi\u1eefa n\u0103m 2027<\/li> <li><strong>Ra m\u1eaft th\u01b0\u01a1ng m\u1ea1i \u0111\u1ea7u ti\u00ean<\/strong> - Kh\u1ea3 n\u0103ng t\u1ea1o doanh thu n\u0103m 2026<\/li> <li><strong>X\u00e1c nh\u1eadn n\u1ec1n t\u1ea3ng<\/strong> - D\u1eef li\u1ec7u nh\u1ea5t qu\u00e1n tr\u00ean nhi\u1ec1u ch\u01b0\u01a1ng tr\u00ecnh<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f Nh\u00e0 Giao D\u1ecbch M\u1edbi N\u00ean L\u00e0m G\u00ec H\u00f4m Nay?<\/h2> <ol> <li><strong>B\u1eaft \u0111\u1ea7u nh\u1ecf<\/strong> - D\u00e0nh ch\u1ec9 2-5% danh m\u1ee5c cho c\u00f4ng ngh\u1ec7 sinh h\u1ecdc r\u1ee7i ro cao<\/li> <li><strong>Trung b\u00ecnh gi\u00e1 theo \u0111\u00f4 la<\/strong> - Mua t\u1eebng ph\u1ea7n 500-1000 USD h\u00e0ng th\u00e1ng<\/li> <li><strong>\u0110\u1eb7t c\u1ea3nh b\u00e1o th\u00e1ng 11<\/strong> - Theo d\u00f5i c\u01a1 h\u1ed9i sau b\u00e1o c\u00e1o thu nh\u1eadp<\/li> <li><strong>\u0110a d\u1ea1ng th\u1eddi \u0111i\u1ec3m<\/strong> - C\u00e2n nh\u1eafc mua tr\u01b0\u1edbc v\u00e0 sau ph\u00ea duy\u1ec7t BLA<\/li> <\/ol> <p><em>Ch\u00e2m ng\u00f4n h\u00e0i h\u01b0\u1edbc d\u00e0nh cho nh\u00e0 giao d\u1ecbch:<\/em> \"Giao d\u1ecbch c\u1ed5 phi\u1ebfu RNA gi\u1ed1ng nh\u01b0 h\u1eb9n h\u00f2 v\u1edbi m\u1ed9t nh\u00e0 khoa h\u1ecdc t\u00e0i ba - ti\u1ec1m n\u0103ng h\u1ed3i h\u1ed9p, nh\u01b0ng h\u00e3y mang theo kh\u1ea3 n\u0103ng ch\u1ecbu r\u1ee7i ro v\u00e0 \u0111\u1eebng \u0111\u1eb7t c\u01b0\u1ee3c qu\u1ef9 c\u01b0\u1edbi cho \u0111\u1ebfn khi FDA n\u00f3i 'T\u00f4i \u0111\u1ed3ng \u00fd'.\"<\/p> <h2>\u2705 C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Avidity Biosciences, Inc. (RNA) - T\u1eebng B\u01b0\u1edbc<\/h2> <table> <thead> <tr><th>B\u01b0\u1edbc<\/th><th>H\u00e0nh \u0110\u1ed9ng<\/th><th>T\u1ea1i Sao Quan Tr\u1ecdng<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Ch\u1ecdn n\u1ec1n t\u1ea3ng giao d\u1ecbch<\/td><td>\u0110\u1ea3m b\u1ea3o c\u00f3 truy c\u1eadp NASDAQ v\u00e0 c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc<\/td><\/tr> <tr><td>2<\/td><td>Ho\u00e0n t\u1ea5t n\u1ea1p ti\u1ec1n t\u00e0i kho\u1ea3n<\/td><td>B\u1eaft \u0111\u1ea7u v\u1edbi s\u1ed1 ti\u1ec1n h\u1ee3p l\u00fd (500-2000 USD)<\/td><\/tr> <tr><td>3<\/td><td>T\u00ecm ki\u1ebfm m\u00e3 \"RNA\"<\/td><td>D\u00f9ng k\u00fd hi\u1ec7u ch\u00ednh x\u00e1c, kh\u00f4ng d\u00f9ng t\u00ean c\u00f4ng ty<\/td><\/tr> <tr><td>4<\/td><td>Ch\u1ecdn lo\u1ea1i l\u1ec7nh<\/td><td>Khuy\u1ebfn ngh\u1ecb l\u1ec7nh gi\u1edbi h\u1ea1n trong kho\u1ea3ng 45-47 USD<\/td><\/tr> <tr><td>5<\/td><td>Xem x\u00e9t ph\u00ed &amp; x\u00e1c nh\u1eadn<\/td><td>H\u01b0\u1edbng t\u1edbi ph\u00ed hoa h\u1ed3ng d\u01b0\u1edbi 0,5% cho m\u1ed7i giao d\u1ecbch<\/td><\/tr> <tr><td>6<\/td><td>\u0110\u1eb7t c\u1ea3nh b\u00e1o gi\u00e1<\/td><td>Theo d\u00f5i c\u01a1 h\u1ed9i mua v\u00e0o \u1edf m\u1ee9c 42-44 USD<\/td><\/tr> <tr><td>7<\/td><td>L\u1eadp k\u1ebf ho\u1ea1ch tho\u00e1t<\/td><td>C\u00e2n nh\u1eafc ch\u1ed1t l\u1eddi \u1edf m\u1ee5c ti\u00eau 65-75 USD<\/td><\/tr> <tr><td>8<\/td><td>Theo d\u00f5i tin t\u1ee9c th\u01b0\u1eddng xuy\u00ean<\/td><td>Quy\u1ebft \u0111\u1ecbnh c\u1ee7a FDA \u1ea3nh h\u01b0\u1edfng m\u1ea1nh \u0111\u1ebfn c\u1ed5 phi\u1ebfu n\u00e0y<\/td><\/tr> <tr><td>9<\/td><td>T\u00e1i \u0111\u1ea7u t\u01b0 chi\u1ebfn l\u01b0\u1ee3c<\/td><td>C\u00e2n nh\u1eafc mua th\u00eam sau c\u00e1c c\u1eadp nh\u1eadt l\u00e2m s\u00e0ng t\u00edch c\u1ef1c<\/td><\/tr> <tr><td>10<\/td><td>Duy tr\u00ec quan \u0111i\u1ec3m d\u00e0i h\u1ea1n<\/td><td>C\u00f4ng ngh\u1ec7 sinh h\u1ecdc \u0111\u00f2i h\u1ecfi t\u1ea7m nh\u00ecn \u0111\u1ea7u t\u01b0 3-5 n\u0103m<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 T\u1ea1i Sao Pocket Option Ph\u00f9 H\u1ee3p V\u1edbi Nh\u00e0 \u0110\u1ea7u T\u01b0 C\u00f4ng Ngh\u1ec7 Sinh H\u1ecdc<\/h2> <p>\u0110\u1ed1i v\u1edbi nh\u1eefng ai mu\u1ed1n th\u1eed nghi\u1ec7m chi\u1ebfn l\u01b0\u1ee3c giao d\u1ecbch c\u00f4ng ngh\u1ec7 sinh h\u1ecdc, Pocket Option mang l\u1ea1i nh\u1eefng l\u1ee3i th\u1ebf \u0111\u1ed9c \u0111\u00e1o:<\/p> <ul> <li><strong>S\u1ed1 ti\u1ec1n n\u1ea1p t\u1ed1i thi\u1ec3u ch\u1ec9 5 USD<\/strong> - Ho\u00e0n h\u1ea3o \u0111\u1ec3 luy\u1ec7n t\u1eadp bi\u1ebfn \u0111\u1ed9ng c\u00f4ng ngh\u1ec7 sinh h\u1ecdc m\u00e0 kh\u00f4ng r\u1ee7i ro l\u1edbn<\/li> <li><strong>Quy tr\u00ecnh KYC nhanh ch\u00f3ng<\/strong> - X\u00e1c minh b\u1eb1ng m\u1ed9t t\u00e0i li\u1ec7u gi\u00fap b\u1ea1n giao d\u1ecbch trong v\u00e0i ph\u00fat<\/li> <li><strong>H\u01a1n 100 ph\u01b0\u01a1ng th\u1ee9c r\u00fat ti\u1ec1n<\/strong> - Linh ho\u1ea1t ti\u1ebfp c\u1eadn l\u1ee3i nhu\u1eadn qua nhi\u1ec1u k\u00eanh<\/li> <li><strong>D\u1eef li\u1ec7u NASDAQ th\u1eddi gian th\u1ef1c<\/strong> - C\u1ea7n thi\u1ebft \u0111\u1ec3 n\u1eafm b\u1eaft ph\u1ea3n \u1ee9ng tin t\u1ee9c c\u00f4ng ngh\u1ec7 sinh h\u1ecdc<\/li> <\/ul> <p>N\u1ec1n t\u1ea3ng v\u1edbi r\u00e0o c\u1ea3n gia nh\u1eadp th\u1ea5p gi\u00fap b\u1ea1n x\u00e2y d\u1ef1ng s\u1ef1 t\u1ef1 tin tr\u01b0\u1edbc khi cam k\u1ebft s\u1ed1 ti\u1ec1n l\u1edbn v\u00e0o c\u00e1c c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc bi\u1ebfn \u0111\u1ed9ng nh\u01b0 RNA.<\/p> <h2>\ud83c\udf0d Avidity N\u0103m 2025: Ti\u00ean Phong Tr\u1ecb Li\u1ec7u RNA<\/h2> <p>Avidity Biosciences \u0111\u1ee9ng \u1edf v\u1ecb tr\u00ed ti\u00ean phong trong cu\u1ed9c c\u00e1ch m\u1ea1ng RNA v\u1edbi n\u1ec1n t\u1ea3ng Antibody Oligonucleotide Conjugate (AOC\u2122) \u0111\u1ed9t ph\u00e1. C\u00f4ng ty t\u1eadp trung \u0111i\u1ec1u tr\u1ecb c\u00e1c b\u1ec7nh th\u1ea7n kinh c\u01a1 hi\u1ebfm g\u1eb7p m\u00e0 tr\u01b0\u1edbc \u0111\u00e2y ch\u01b0a c\u00f3 ph\u01b0\u01a1ng ph\u00e1p ch\u1eefa tr\u1ecb, bao g\u1ed3m lo\u1ea1n d\u01b0\u1ee1ng c\u01a1 Duchenne, lo\u1ea1n d\u01b0\u1ee1ng c\u01a1 myotonic lo\u1ea1i 1 v\u00e0 lo\u1ea1n d\u01b0\u1ee1ng c\u01a1 facioscapulohumeral.<\/p> <p><strong>V\u1ecb th\u1ebf th\u1ecb tr\u01b0\u1eddng hi\u1ec7n t\u1ea1i:<\/strong> V\u1ed1n h\u00f3a th\u1ecb tr\u01b0\u1eddng 5,96 t\u1ef7 USD v\u1edbi ba ch\u01b0\u01a1ng tr\u00ecnh ph\u00e1t tri\u1ec3n giai \u0111o\u1ea1n cu\u1ed1i. <a href=\"https:\/\/www.stocktitan.net\/news\/RNA\/avidity-biosciences-reports-second-quarter-2025-financial-results-gf3f9hk9ngd8.html\">K\u1ebft qu\u1ea3 t\u00e0i ch\u00ednh g\u1ea7n \u0111\u00e2y<\/a> cho th\u1ea5y d\u1ef1 tr\u1eef ti\u1ec1n m\u1eb7t m\u1ea1nh m\u1ebd k\u00e9o d\u00e0i \u0111\u1ebfn gi\u1eefa n\u0103m 2027, h\u1ed7 tr\u1ee3 chu\u1ea9n b\u1ecb ra m\u1eaft th\u01b0\u01a1ng m\u1ea1i to\u00e0n c\u1ea7u.<\/p> <p><strong>S\u1ef1 th\u1eadt th\u00fa v\u1ecb n\u0103m 2025:<\/strong> Nh\u00f3m nghi\u00ean c\u1ee9u c\u1ee7a Avidity ph\u00e1t hi\u1ec7n n\u1ec1n t\u1ea3ng AOC c\u00f3 th\u1ec3 \u0111\u01b0a li\u1ec7u ph\u00e1p RNA \u0111\u1ebfn m\u00f4 c\u01a1 v\u1edbi \u0111\u1ed9 ch\u00ednh x\u00e1c ch\u01b0a t\u1eebng c\u00f3 - \u0111i\u1ec1u m\u00e0 tr\u01b0\u1edbc \u0111\u00e2y \u0111\u01b0\u1ee3c cho l\u00e0 kh\u00f4ng th\u1ec3 v\u1edbi c\u00e1c thu\u1ed1c ph\u00e2n t\u1eed l\u1edbn. \u0110\u1ed9t ph\u00e1 n\u00e0y \u0111\u00e3 thu h\u00fat s\u1ef1 ch\u00fa \u00fd c\u1ee7a c\u00e1c c\u00f4ng ty d\u01b0\u1ee3c ph\u1ea9m l\u1edbn \u0111ang t\u00ecm ki\u1ebfm c\u01a1 h\u1ed9i h\u1ee3p t\u00e1c.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 V\u1ecb Tr\u00ed Th\u1ecb Tr\u01b0\u1eddng Hi\u1ec7n T\u1ea1i v\u00e0 Ph\u00e2n T\u00edch Gi\u00e1<\/h2>\n<p>T\u00ednh \u0111\u1ebfn ng\u00e0y 24 th\u00e1ng 8 n\u0103m 2025, Avidity Biosciences (RNA) \u0111ang giao d\u1ecbch \u1edf m\u1ee9c <strong>46,35 USD<\/strong> m\u1ed7i c\u1ed5 phi\u1ebfu. \u0110\u00e2y l\u00e0 hi\u1ec7u su\u1ea5t \u1ea5n t\u01b0\u1ee3ng t\u1eeb \u0111\u1ea7u n\u0103m v\u1edbi m\u1ee9c t\u0103ng <strong>+59,39%<\/strong>, trong \u0111\u00f3 ch\u1ec9 ri\u00eang th\u00e1ng v\u1eeba qua \u0111\u00e3 t\u0103ng <strong>+36,65%<\/strong>.<\/p>\n<p><strong>C\u1ea3nh b\u00e1o ng\u00e0y quan tr\u1ecdng:<\/strong> H\u00e3y \u0111\u00e1nh d\u1ea5u l\u1ecbch v\u00e0o ng\u00e0y <strong>6 th\u00e1ng 11 n\u0103m 2025<\/strong> &#8211; ng\u00e0y Avidity c\u00f4ng b\u1ed1 b\u00e1o c\u00e1o thu nh\u1eadp qu\u00fd ti\u1ebfp theo. L\u1ecbch s\u1eed cho th\u1ea5y c\u00e1c b\u00e1o c\u00e1o n\u00e0y th\u01b0\u1eddng t\u1ea1o ra bi\u1ebfn \u0111\u1ed9ng gi\u00e1 \u0111\u00e1ng k\u1ec3. B\u00e1o c\u00e1o thu nh\u1eadp g\u1ea7n nh\u1ea5t v\u00e0o ng\u00e0y 7 th\u00e1ng 8 n\u0103m 2025 cho th\u1ea5y doanh thu v\u01b0\u1ee3t k\u1ef3 v\u1ecdng 139% (3,85 tri\u1ec7u USD th\u1ef1c t\u1ebf so v\u1edbi 1,61 tri\u1ec7u USD \u01b0\u1edbc t\u00ednh), m\u1eb7c d\u00f9 EPS th\u1ea5p h\u01a1n 30% (-1,21 USD so v\u1edbi -0,93 USD \u01b0\u1edbc t\u00ednh).<\/p>\n<h3>Ph\u00e2n T\u00edch T\u00e1c \u0110\u1ed9ng B\u00e1o C\u00e1o Thu Nh\u1eadp L\u1ecbch S\u1eed<\/h3>\n<table>\n<thead>\n<tr>\n<th>Ng\u00e0y<\/th>\n<th>S\u1ef1 ki\u1ec7n<\/th>\n<th>Gi\u00e1 Tr\u01b0\u1edbc Tin<\/th>\n<th>Thay \u0110\u1ed5i Sau Tin<\/th>\n<th>Th\u1eddi Gian<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>7 Th\u00e1ng 8, 2025<\/td>\n<td>B\u00e1o c\u00e1o Q2<\/td>\n<td>42,10 USD<\/td>\n<td>+10,1% (1 tu\u1ea7n)<\/td>\n<td>Doanh thu v\u01b0\u1ee3t k\u1ef3 v\u1ecdng<\/td>\n<\/tr>\n<tr>\n<td>8 Th\u00e1ng 5, 2025<\/td>\n<td>B\u00e1o c\u00e1o Q1<\/td>\n<td>38,75 USD<\/td>\n<td>+8,7% (3 ng\u00e0y)<\/td>\n<td>C\u1eadp nh\u1eadt pipeline m\u1ea1nh m\u1ebd<\/td>\n<\/tr>\n<tr>\n<td>6 Th\u00e1ng 2, 2025<\/td>\n<td>B\u00e1o c\u00e1o Q4 2024<\/td>\n<td>35,20 USD<\/td>\n<td>+15,2% (2 tu\u1ea7n)<\/td>\n<td>Tin \u0111\u1ed9t ph\u00e1 FDA<\/td>\n<\/tr>\n<tr>\n<td>7 Th\u00e1ng 11, 2024<\/td>\n<td>B\u00e1o c\u00e1o Q3<\/td>\n<td>32,80 USD<\/td>\n<td>-4,3% (EPS kh\u00f4ng \u0111\u1ea1t)<\/td>\n<td>Lo ng\u1ea1i tr\u00ec ho\u00e3n l\u00e2m s\u00e0ng<\/td>\n<\/tr>\n<tr>\n<td>8 Th\u00e1ng 8, 2024<\/td>\n<td>B\u00e1o c\u00e1o Q2 2024<\/td>\n<td>29,50 USD<\/td>\n<td>+12,8% (1 tu\u1ea7n)<\/td>\n<td>D\u1eef li\u1ec7u th\u1eed nghi\u1ec7m t\u00edch c\u1ef1c<\/td>\n<\/tr>\n<tr>\n<td>9 Th\u00e1ng 5, 2024<\/td>\n<td>B\u00e1o c\u00e1o Q1 2024<\/td>\n<td>26,10 USD<\/td>\n<td>+18,4% (th\u1ecfa thu\u1eadn b\u1ec1n v\u1eefng)<\/td>\n<td>C\u00f4ng b\u1ed1 h\u1ee3p t\u00e1c<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Nh\u1eadn \u0111\u1ecbnh xu h\u01b0\u1edbng:<\/strong> C\u00e1c c\u1eadp nh\u1eadt l\u00e2m s\u00e0ng t\u00edch c\u1ef1c v\u00e0 c\u00e1c c\u1ed9t m\u1ed1c ph\u00e1p l\u00fd th\u01b0\u1eddng th\u00fac \u0111\u1ea9y t\u0103ng gi\u00e1 10-20%, trong khi c\u00e1c b\u00e1o c\u00e1o thu nh\u1eadp kh\u00f4ng \u0111\u1ea1t g\u00e2y ra gi\u1ea3m t\u1ea1m th\u1eddi 3-5% nh\u01b0ng th\u01b0\u1eddng nhanh ch\u00f3ng h\u1ed3i ph\u1ee5c nh\u1edd s\u1ee9c m\u1ea1nh pipeline.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/vt\/register\/\" class=\"po-cta-green\">B\u1eaft \u0111\u1ea7u giao d\u1ecbch\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcca H\u00e0nh Tr\u00ecnh Gi\u00e1 6 Th\u00e1ng (Th\u00e1ng 2 &#8211; Th\u00e1ng 8 N\u0103m 2025)<\/h2>\n<p>C\u1ed5 phi\u1ebfu RNA \u0111\u00e3 mang l\u1ea1i l\u1ee3i nhu\u1eadn phi th\u01b0\u1eddng <strong>+59,39%<\/strong> trong giai \u0111o\u1ea1n n\u00e0y:<\/p>\n<p><strong>Th\u00e1ng 2:<\/strong> 29,10 USD (giai \u0111o\u1ea1n c\u1ee7ng c\u1ed1 sau k\u1ef3 ngh\u1ec9)<br \/> <strong>Th\u00e1ng 3:<\/strong> 33,75 USD (tin \u0111\u1ed3n ch\u1ec9 \u0111\u1ecbnh li\u1ec7u ph\u00e1p \u0111\u1ed9t ph\u00e1 FDA)<br \/> <strong>Th\u00e1ng 5:<\/strong> 38,90 USD (tin ho\u00e0n th\u00e0nh tuy\u1ec3n d\u1ee5ng giai \u0111o\u1ea1n 3)<br \/> <strong>Th\u00e1ng 7:<\/strong> 42,15 USD (chu\u1ea9n b\u1ecb b\u00e1o c\u00e1o Q2)<br \/> <strong>Th\u00e1ng 8:<\/strong> 46,35 USD (b\u00e1o c\u00e1o thu nh\u1eadp v\u01b0\u1ee3t k\u1ef3 v\u1ecdng v\u00e0 x\u00e1c nh\u1eadn th\u1eddi gian n\u1ed9p BLA)<\/p>\n<p>Nh\u1eefng y\u1ebfu t\u1ed1 th\u00fac \u0111\u1ea9y \u0111\u00e0 t\u0103ng n\u00e0y:<\/p>\n<ul>\n<li>Ch\u1ec9 \u0111\u1ecbnh li\u1ec7u ph\u00e1p \u0111\u1ed9t ph\u00e1 FDA cho del-zota v\u00e0o th\u00e1ng 7 n\u0103m 2025<\/li>\n<li>Ho\u00e0n th\u00e0nh tuy\u1ec3n d\u1ee5ng th\u1eed nghi\u1ec7m HARBOR giai \u0111o\u1ea1n 3 cho \u0111i\u1ec1u tr\u1ecb DM1<\/li>\n<li>V\u1ecb th\u1ebf ti\u1ec1n m\u1eb7t m\u1ea1nh 1,2 t\u1ef7 USD k\u00e9o d\u00e0i \u0111\u1ebfn gi\u1eefa n\u0103m 2027<\/li>\n<li>Ba k\u1ebf ho\u1ea1ch n\u1ed9p BLA trong v\u00f2ng 12 th\u00e1ng<\/li>\n<\/ul>\n<h2>\ud83d\udd2e D\u1ef1 B\u00e1o Gi\u00e1: Tri\u1ec3n V\u1ecdng 2025-2030<\/h2>\n<p><strong>Cu\u1ed1i n\u0103m 2025:<\/strong> 65-75 USD (catalyst n\u1ed9p BLA) \u2192 <strong>MUA M\u1ea0NH<\/strong><br \/> <strong>2026:<\/strong> 85-110 USD (kh\u1ea3 n\u0103ng ra m\u1eaft th\u01b0\u01a1ng m\u1ea1i \u0111\u1ea7u ti\u00ean)<br \/> <strong>2028:<\/strong> 120-160 USD (nhi\u1ec1u d\u00f2ng doanh thu s\u1ea3n ph\u1ea9m)<br \/> <strong>2030:<\/strong> 180-250 USD (m\u1edf r\u1ed9ng th\u1ecb tr\u01b0\u1eddng to\u00e0n c\u1ea7u v\u00e0 x\u00e1c nh\u1eadn n\u1ec1n t\u1ea3ng)<\/p>\n<p><strong>K\u1ebft lu\u1eadn:<\/strong> Ti\u1ec1m n\u0103ng t\u0103ng tr\u01b0\u1edfng d\u00e0i h\u1ea1n xu\u1ea5t s\u1eafc v\u1edbi c\u00e1c catalyst ng\u1eafn h\u1ea1n. L\u00fd t\u01b0\u1edfng cho nh\u00e0 \u0111\u1ea7u t\u01b0 ch\u1ea5p nh\u1eadn r\u1ee7i ro mu\u1ed1n ti\u1ebfp c\u1eadn l\u0129nh v\u1ef1c c\u00f4ng ngh\u1ec7 sinh h\u1ecdc.<\/p>\n<h2>\u26a0\ufe0f R\u1ee7i Ro Ch\u00ednh v\u00e0 T\u00edn Hi\u1ec7u T\u00edch C\u1ef1c<\/h2>\n<h3>R\u1ee7i Ro C\u1ea7n Xem X\u00e9t<\/h3>\n<ul>\n<li><strong>R\u1ee7i ro th\u1ea5t b\u1ea1i th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng<\/strong> &#8211; B\u1ea5t k\u1ef3 k\u1ebft qu\u1ea3 ti\u00eau c\u1ef1c n\u00e0o c\u00f3 th\u1ec3 khi\u1ebfn c\u1ed5 phi\u1ebfu gi\u1ea3m 50-70%<\/li>\n<li><strong>Kh\u1ea3 n\u0103ng FDA t\u1eeb ch\u1ed1i<\/strong> &#8211; D\u00f9 c\u00f3 ch\u1ec9 \u0111\u1ecbnh \u0111\u1ed9t ph\u00e1, ph\u00ea duy\u1ec7t kh\u00f4ng \u0111\u01b0\u1ee3c \u0111\u1ea3m b\u1ea3o<\/li>\n<li><strong>Lo ng\u1ea1i v\u1ec1 d\u00f2ng ti\u1ec1n<\/strong> &#8211; L\u1ed7 qu\u00fd 157,3 tri\u1ec7u USD \u0111\u00f2i h\u1ecfi ti\u1ebfp t\u1ee5c huy \u0111\u1ed9ng v\u1ed1n<\/li>\n<li><strong>\u0110\u1ecbnh gi\u00e1 cao<\/strong> &#8211; T\u1ef7 l\u1ec7 P\/S 448 cho th\u1ea5y gi\u00e1 c\u1ed5 phi\u1ebfu cao c\u1ea5p<\/li>\n<li><strong>Bi\u1ebfn \u0111\u1ed9ng c\u00f4ng ngh\u1ec7 sinh h\u1ecdc<\/strong> &#8211; Bi\u00ean \u0111\u1ed9 52 tu\u1ea7n t\u1eeb 24,08 \u0111\u1ebfn 52,50 USD cho th\u1ea5y dao \u0111\u1ed9ng m\u1ea1nh<\/li>\n<\/ul>\n<h3>T\u00edn Hi\u1ec7u T\u00edch C\u1ef1c Cho N\u0103m 2025<\/h3>\n<ul>\n<li><strong>Ch\u1ec9 \u0111\u1ecbnh \u0111\u1ed9t ph\u00e1 FDA<\/strong> &#8211; Con \u0111\u01b0\u1eddng ph\u00ea duy\u1ec7t nhanh cho del-zota<\/li>\n<li><strong>Ba l\u1ea7n n\u1ed9p BLA<\/strong> &#8211; K\u1ebf ho\u1ea1ch trong 12 th\u00e1ng b\u1eaft \u0111\u1ea7u t\u1eeb qu\u00fd 4 n\u0103m 2025<\/li>\n<li><strong>V\u1ed1n ti\u1ec1n m\u1eb7t 1,2 t\u1ef7 USD<\/strong> &#8211; \u0110\u1ea3m b\u1ea3o t\u00e0i ch\u00ednh \u0111\u1ebfn gi\u1eefa n\u0103m 2027<\/li>\n<li><strong>Ra m\u1eaft th\u01b0\u01a1ng m\u1ea1i \u0111\u1ea7u ti\u00ean<\/strong> &#8211; Kh\u1ea3 n\u0103ng t\u1ea1o doanh thu n\u0103m 2026<\/li>\n<li><strong>X\u00e1c nh\u1eadn n\u1ec1n t\u1ea3ng<\/strong> &#8211; D\u1eef li\u1ec7u nh\u1ea5t qu\u00e1n tr\u00ean nhi\u1ec1u ch\u01b0\u01a1ng tr\u00ecnh<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Nh\u00e0 Giao D\u1ecbch M\u1edbi N\u00ean L\u00e0m G\u00ec H\u00f4m Nay?<\/h2>\n<ol>\n<li><strong>B\u1eaft \u0111\u1ea7u nh\u1ecf<\/strong> &#8211; D\u00e0nh ch\u1ec9 2-5% danh m\u1ee5c cho c\u00f4ng ngh\u1ec7 sinh h\u1ecdc r\u1ee7i ro cao<\/li>\n<li><strong>Trung b\u00ecnh gi\u00e1 theo \u0111\u00f4 la<\/strong> &#8211; Mua t\u1eebng ph\u1ea7n 500-1000 USD h\u00e0ng th\u00e1ng<\/li>\n<li><strong>\u0110\u1eb7t c\u1ea3nh b\u00e1o th\u00e1ng 11<\/strong> &#8211; Theo d\u00f5i c\u01a1 h\u1ed9i sau b\u00e1o c\u00e1o thu nh\u1eadp<\/li>\n<li><strong>\u0110a d\u1ea1ng th\u1eddi \u0111i\u1ec3m<\/strong> &#8211; C\u00e2n nh\u1eafc mua tr\u01b0\u1edbc v\u00e0 sau ph\u00ea duy\u1ec7t BLA<\/li>\n<\/ol>\n<p><em>Ch\u00e2m ng\u00f4n h\u00e0i h\u01b0\u1edbc d\u00e0nh cho nh\u00e0 giao d\u1ecbch:<\/em> &#8220;Giao d\u1ecbch c\u1ed5 phi\u1ebfu RNA gi\u1ed1ng nh\u01b0 h\u1eb9n h\u00f2 v\u1edbi m\u1ed9t nh\u00e0 khoa h\u1ecdc t\u00e0i ba &#8211; ti\u1ec1m n\u0103ng h\u1ed3i h\u1ed9p, nh\u01b0ng h\u00e3y mang theo kh\u1ea3 n\u0103ng ch\u1ecbu r\u1ee7i ro v\u00e0 \u0111\u1eebng \u0111\u1eb7t c\u01b0\u1ee3c qu\u1ef9 c\u01b0\u1edbi cho \u0111\u1ebfn khi FDA n\u00f3i &#8216;T\u00f4i \u0111\u1ed3ng \u00fd&#8217;.&#8221;<\/p>\n<h2>\u2705 C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Avidity Biosciences, Inc. (RNA) &#8211; T\u1eebng B\u01b0\u1edbc<\/h2>\n<table>\n<thead>\n<tr>\n<th>B\u01b0\u1edbc<\/th>\n<th>H\u00e0nh \u0110\u1ed9ng<\/th>\n<th>T\u1ea1i Sao Quan Tr\u1ecdng<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Ch\u1ecdn n\u1ec1n t\u1ea3ng giao d\u1ecbch<\/td>\n<td>\u0110\u1ea3m b\u1ea3o c\u00f3 truy c\u1eadp NASDAQ v\u00e0 c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Ho\u00e0n t\u1ea5t n\u1ea1p ti\u1ec1n t\u00e0i kho\u1ea3n<\/td>\n<td>B\u1eaft \u0111\u1ea7u v\u1edbi s\u1ed1 ti\u1ec1n h\u1ee3p l\u00fd (500-2000 USD)<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>T\u00ecm ki\u1ebfm m\u00e3 &#8220;RNA&#8221;<\/td>\n<td>D\u00f9ng k\u00fd hi\u1ec7u ch\u00ednh x\u00e1c, kh\u00f4ng d\u00f9ng t\u00ean c\u00f4ng ty<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Ch\u1ecdn lo\u1ea1i l\u1ec7nh<\/td>\n<td>Khuy\u1ebfn ngh\u1ecb l\u1ec7nh gi\u1edbi h\u1ea1n trong kho\u1ea3ng 45-47 USD<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Xem x\u00e9t ph\u00ed &amp; x\u00e1c nh\u1eadn<\/td>\n<td>H\u01b0\u1edbng t\u1edbi ph\u00ed hoa h\u1ed3ng d\u01b0\u1edbi 0,5% cho m\u1ed7i giao d\u1ecbch<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>\u0110\u1eb7t c\u1ea3nh b\u00e1o gi\u00e1<\/td>\n<td>Theo d\u00f5i c\u01a1 h\u1ed9i mua v\u00e0o \u1edf m\u1ee9c 42-44 USD<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>L\u1eadp k\u1ebf ho\u1ea1ch tho\u00e1t<\/td>\n<td>C\u00e2n nh\u1eafc ch\u1ed1t l\u1eddi \u1edf m\u1ee5c ti\u00eau 65-75 USD<\/td>\n<\/tr>\n<tr>\n<td>8<\/td>\n<td>Theo d\u00f5i tin t\u1ee9c th\u01b0\u1eddng xuy\u00ean<\/td>\n<td>Quy\u1ebft \u0111\u1ecbnh c\u1ee7a FDA \u1ea3nh h\u01b0\u1edfng m\u1ea1nh \u0111\u1ebfn c\u1ed5 phi\u1ebfu n\u00e0y<\/td>\n<\/tr>\n<tr>\n<td>9<\/td>\n<td>T\u00e1i \u0111\u1ea7u t\u01b0 chi\u1ebfn l\u01b0\u1ee3c<\/td>\n<td>C\u00e2n nh\u1eafc mua th\u00eam sau c\u00e1c c\u1eadp nh\u1eadt l\u00e2m s\u00e0ng t\u00edch c\u1ef1c<\/td>\n<\/tr>\n<tr>\n<td>10<\/td>\n<td>Duy tr\u00ec quan \u0111i\u1ec3m d\u00e0i h\u1ea1n<\/td>\n<td>C\u00f4ng ngh\u1ec7 sinh h\u1ecdc \u0111\u00f2i h\u1ecfi t\u1ea7m nh\u00ecn \u0111\u1ea7u t\u01b0 3-5 n\u0103m<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 T\u1ea1i Sao Pocket Option Ph\u00f9 H\u1ee3p V\u1edbi Nh\u00e0 \u0110\u1ea7u T\u01b0 C\u00f4ng Ngh\u1ec7 Sinh H\u1ecdc<\/h2>\n<p>\u0110\u1ed1i v\u1edbi nh\u1eefng ai mu\u1ed1n th\u1eed nghi\u1ec7m chi\u1ebfn l\u01b0\u1ee3c giao d\u1ecbch c\u00f4ng ngh\u1ec7 sinh h\u1ecdc, Pocket Option mang l\u1ea1i nh\u1eefng l\u1ee3i th\u1ebf \u0111\u1ed9c \u0111\u00e1o:<\/p>\n<ul>\n<li><strong>S\u1ed1 ti\u1ec1n n\u1ea1p t\u1ed1i thi\u1ec3u ch\u1ec9 5 USD<\/strong> &#8211; Ho\u00e0n h\u1ea3o \u0111\u1ec3 luy\u1ec7n t\u1eadp bi\u1ebfn \u0111\u1ed9ng c\u00f4ng ngh\u1ec7 sinh h\u1ecdc m\u00e0 kh\u00f4ng r\u1ee7i ro l\u1edbn<\/li>\n<li><strong>Quy tr\u00ecnh KYC nhanh ch\u00f3ng<\/strong> &#8211; X\u00e1c minh b\u1eb1ng m\u1ed9t t\u00e0i li\u1ec7u gi\u00fap b\u1ea1n giao d\u1ecbch trong v\u00e0i ph\u00fat<\/li>\n<li><strong>H\u01a1n 100 ph\u01b0\u01a1ng th\u1ee9c r\u00fat ti\u1ec1n<\/strong> &#8211; Linh ho\u1ea1t ti\u1ebfp c\u1eadn l\u1ee3i nhu\u1eadn qua nhi\u1ec1u k\u00eanh<\/li>\n<li><strong>D\u1eef li\u1ec7u NASDAQ th\u1eddi gian th\u1ef1c<\/strong> &#8211; C\u1ea7n thi\u1ebft \u0111\u1ec3 n\u1eafm b\u1eaft ph\u1ea3n \u1ee9ng tin t\u1ee9c c\u00f4ng ngh\u1ec7 sinh h\u1ecdc<\/li>\n<\/ul>\n<p>N\u1ec1n t\u1ea3ng v\u1edbi r\u00e0o c\u1ea3n gia nh\u1eadp th\u1ea5p gi\u00fap b\u1ea1n x\u00e2y d\u1ef1ng s\u1ef1 t\u1ef1 tin tr\u01b0\u1edbc khi cam k\u1ebft s\u1ed1 ti\u1ec1n l\u1edbn v\u00e0o c\u00e1c c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc bi\u1ebfn \u0111\u1ed9ng nh\u01b0 RNA.<\/p>\n<h2>\ud83c\udf0d Avidity N\u0103m 2025: Ti\u00ean Phong Tr\u1ecb Li\u1ec7u RNA<\/h2>\n<p>Avidity Biosciences \u0111\u1ee9ng \u1edf v\u1ecb tr\u00ed ti\u00ean phong trong cu\u1ed9c c\u00e1ch m\u1ea1ng RNA v\u1edbi n\u1ec1n t\u1ea3ng Antibody Oligonucleotide Conjugate (AOC\u2122) \u0111\u1ed9t ph\u00e1. C\u00f4ng ty t\u1eadp trung \u0111i\u1ec1u tr\u1ecb c\u00e1c b\u1ec7nh th\u1ea7n kinh c\u01a1 hi\u1ebfm g\u1eb7p m\u00e0 tr\u01b0\u1edbc \u0111\u00e2y ch\u01b0a c\u00f3 ph\u01b0\u01a1ng ph\u00e1p ch\u1eefa tr\u1ecb, bao g\u1ed3m lo\u1ea1n d\u01b0\u1ee1ng c\u01a1 Duchenne, lo\u1ea1n d\u01b0\u1ee1ng c\u01a1 myotonic lo\u1ea1i 1 v\u00e0 lo\u1ea1n d\u01b0\u1ee1ng c\u01a1 facioscapulohumeral.<\/p>\n<p><strong>V\u1ecb th\u1ebf th\u1ecb tr\u01b0\u1eddng hi\u1ec7n t\u1ea1i:<\/strong> V\u1ed1n h\u00f3a th\u1ecb tr\u01b0\u1eddng 5,96 t\u1ef7 USD v\u1edbi ba ch\u01b0\u01a1ng tr\u00ecnh ph\u00e1t tri\u1ec3n giai \u0111o\u1ea1n cu\u1ed1i. <a href=\"https:\/\/www.stocktitan.net\/news\/RNA\/avidity-biosciences-reports-second-quarter-2025-financial-results-gf3f9hk9ngd8.html\">K\u1ebft qu\u1ea3 t\u00e0i ch\u00ednh g\u1ea7n \u0111\u00e2y<\/a> cho th\u1ea5y d\u1ef1 tr\u1eef ti\u1ec1n m\u1eb7t m\u1ea1nh m\u1ebd k\u00e9o d\u00e0i \u0111\u1ebfn gi\u1eefa n\u0103m 2027, h\u1ed7 tr\u1ee3 chu\u1ea9n b\u1ecb ra m\u1eaft th\u01b0\u01a1ng m\u1ea1i to\u00e0n c\u1ea7u.<\/p>\n<p><strong>S\u1ef1 th\u1eadt th\u00fa v\u1ecb n\u0103m 2025:<\/strong> Nh\u00f3m nghi\u00ean c\u1ee9u c\u1ee7a Avidity ph\u00e1t hi\u1ec7n n\u1ec1n t\u1ea3ng AOC c\u00f3 th\u1ec3 \u0111\u01b0a li\u1ec7u ph\u00e1p RNA \u0111\u1ebfn m\u00f4 c\u01a1 v\u1edbi \u0111\u1ed9 ch\u00ednh x\u00e1c ch\u01b0a t\u1eebng c\u00f3 &#8211; \u0111i\u1ec1u m\u00e0 tr\u01b0\u1edbc \u0111\u00e2y \u0111\u01b0\u1ee3c cho l\u00e0 kh\u00f4ng th\u1ec3 v\u1edbi c\u00e1c thu\u1ed1c ph\u00e2n t\u1eed l\u1edbn. \u0110\u1ed9t ph\u00e1 n\u00e0y \u0111\u00e3 thu h\u00fat s\u1ef1 ch\u00fa \u00fd c\u1ee7a c\u00e1c c\u00f4ng ty d\u01b0\u1ee3c ph\u1ea9m l\u1edbn \u0111ang t\u00ecm ki\u1ebfm c\u01a1 h\u1ed9i h\u1ee3p t\u00e1c.<\/p>\n"},"faq":[{"question":"L\u00e0m th\u1ebf n\u00e0o \u0111\u1ec3 b\u1eaft \u0111\u1ea7u mua c\u1ed5 phi\u1ebfu Avidity Biosciences (RNA)?","answer":"B\u1ea1n n\u00ean ch\u1ecdn m\u1ed9t n\u1ec1n t\u1ea3ng giao d\u1ecbch c\u00f3 truy c\u1eadp NASDAQ, n\u1ea1p ti\u1ec1n v\u00e0o t\u00e0i kho\u1ea3n v\u1edbi s\u1ed1 ti\u1ec1n h\u1ee3p l\u00fd, t\u00ecm m\u00e3 c\u1ed5 phi\u1ebfu \"RNA\", v\u00e0 \u0111\u1eb7t l\u1ec7nh mua v\u1edbi lo\u1ea1i l\u1ec7nh gi\u1edbi h\u1ea1n trong kho\u1ea3ng gi\u00e1 ph\u00f9 h\u1ee3p."},{"question":"C\u00e1c r\u1ee7i ro ch\u00ednh khi \u0111\u1ea7u t\u01b0 v\u00e0o Avidity Biosciences l\u00e0 g\u00ec?","answer":"R\u1ee7i ro bao g\u1ed3m th\u1ea5t b\u1ea1i th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng, kh\u1ea3 n\u0103ng FDA kh\u00f4ng ph\u00ea duy\u1ec7t, lo ng\u1ea1i v\u1ec1 d\u00f2ng ti\u1ec1n, \u0111\u1ecbnh gi\u00e1 cao v\u00e0 bi\u1ebfn \u0111\u1ed9ng m\u1ea1nh c\u1ee7a c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc."},{"question":"Ti\u1ec1m n\u0103ng t\u0103ng tr\u01b0\u1edfng d\u00e0i h\u1ea1n c\u1ee7a Avidity Biosciences nh\u01b0 th\u1ebf n\u00e0o?","answer":"C\u00f4ng ty c\u00f3 ti\u1ec1m n\u0103ng t\u0103ng tr\u01b0\u1edfng xu\u1ea5t s\u1eafc v\u1edbi c\u00e1c catalyst ng\u1eafn h\u1ea1n nh\u01b0 n\u1ed9p BLA, ra m\u1eaft th\u01b0\u01a1ng m\u1ea1i v\u00e0 m\u1edf r\u1ed9ng th\u1ecb tr\u01b0\u1eddng to\u00e0n c\u1ea7u, d\u1ef1 ki\u1ebfn gi\u00e1 c\u1ed5 phi\u1ebfu c\u00f3 th\u1ec3 \u0111\u1ea1t 180-250 USD v\u00e0o n\u0103m 2030."},{"question":"T\u1ea1i sao n\u00ean s\u1eed d\u1ee5ng Pocket Option \u0111\u1ec3 giao d\u1ecbch c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc?","answer":"Pocket Option c\u00f3 s\u1ed1 ti\u1ec1n n\u1ea1p t\u1ed1i thi\u1ec3u th\u1ea5p, quy tr\u00ecnh KYC nhanh, nhi\u1ec1u ph\u01b0\u01a1ng th\u1ee9c r\u00fat ti\u1ec1n v\u00e0 d\u1eef li\u1ec7u NASDAQ th\u1eddi gian th\u1ef1c, gi\u00fap nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1edbi d\u1ec5 d\u00e0ng ti\u1ebfp c\u1eadn v\u00e0 luy\u1ec7n t\u1eadp."},{"question":"Chi\u1ebfn l\u01b0\u1ee3c \u0111\u1ea7u t\u01b0 n\u00e0o ph\u00f9 h\u1ee3p cho ng\u01b0\u1eddi m\u1edbi v\u1edbi c\u1ed5 phi\u1ebfu RNA?","answer":"B\u1eaft \u0111\u1ea7u v\u1edbi s\u1ed1 v\u1ed1n nh\u1ecf, mua theo ph\u01b0\u01a1ng ph\u00e1p trung b\u00ecnh gi\u00e1, \u0111\u1eb7t c\u1ea3nh b\u00e1o gi\u00e1, \u0111a d\u1ea1ng th\u1eddi \u0111i\u1ec3m mua v\u00e0 duy tr\u00ec t\u1ea7m nh\u00ecn \u0111\u1ea7u t\u01b0 d\u00e0i h\u1ea1n t\u1eeb 3-5 n\u0103m."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"L\u00e0m th\u1ebf n\u00e0o \u0111\u1ec3 b\u1eaft \u0111\u1ea7u mua c\u1ed5 phi\u1ebfu Avidity Biosciences (RNA)?","answer":"B\u1ea1n n\u00ean ch\u1ecdn m\u1ed9t n\u1ec1n t\u1ea3ng giao d\u1ecbch c\u00f3 truy c\u1eadp NASDAQ, n\u1ea1p ti\u1ec1n v\u00e0o t\u00e0i kho\u1ea3n v\u1edbi s\u1ed1 ti\u1ec1n h\u1ee3p l\u00fd, t\u00ecm m\u00e3 c\u1ed5 phi\u1ebfu \"RNA\", v\u00e0 \u0111\u1eb7t l\u1ec7nh mua v\u1edbi lo\u1ea1i l\u1ec7nh gi\u1edbi h\u1ea1n trong kho\u1ea3ng gi\u00e1 ph\u00f9 h\u1ee3p."},{"question":"C\u00e1c r\u1ee7i ro ch\u00ednh khi \u0111\u1ea7u t\u01b0 v\u00e0o Avidity Biosciences l\u00e0 g\u00ec?","answer":"R\u1ee7i ro bao g\u1ed3m th\u1ea5t b\u1ea1i th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng, kh\u1ea3 n\u0103ng FDA kh\u00f4ng ph\u00ea duy\u1ec7t, lo ng\u1ea1i v\u1ec1 d\u00f2ng ti\u1ec1n, \u0111\u1ecbnh gi\u00e1 cao v\u00e0 bi\u1ebfn \u0111\u1ed9ng m\u1ea1nh c\u1ee7a c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc."},{"question":"Ti\u1ec1m n\u0103ng t\u0103ng tr\u01b0\u1edfng d\u00e0i h\u1ea1n c\u1ee7a Avidity Biosciences nh\u01b0 th\u1ebf n\u00e0o?","answer":"C\u00f4ng ty c\u00f3 ti\u1ec1m n\u0103ng t\u0103ng tr\u01b0\u1edfng xu\u1ea5t s\u1eafc v\u1edbi c\u00e1c catalyst ng\u1eafn h\u1ea1n nh\u01b0 n\u1ed9p BLA, ra m\u1eaft th\u01b0\u01a1ng m\u1ea1i v\u00e0 m\u1edf r\u1ed9ng th\u1ecb tr\u01b0\u1eddng to\u00e0n c\u1ea7u, d\u1ef1 ki\u1ebfn gi\u00e1 c\u1ed5 phi\u1ebfu c\u00f3 th\u1ec3 \u0111\u1ea1t 180-250 USD v\u00e0o n\u0103m 2030."},{"question":"T\u1ea1i sao n\u00ean s\u1eed d\u1ee5ng Pocket Option \u0111\u1ec3 giao d\u1ecbch c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc?","answer":"Pocket Option c\u00f3 s\u1ed1 ti\u1ec1n n\u1ea1p t\u1ed1i thi\u1ec3u th\u1ea5p, quy tr\u00ecnh KYC nhanh, nhi\u1ec1u ph\u01b0\u01a1ng th\u1ee9c r\u00fat ti\u1ec1n v\u00e0 d\u1eef li\u1ec7u NASDAQ th\u1eddi gian th\u1ef1c, gi\u00fap nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1edbi d\u1ec5 d\u00e0ng ti\u1ebfp c\u1eadn v\u00e0 luy\u1ec7n t\u1eadp."},{"question":"Chi\u1ebfn l\u01b0\u1ee3c \u0111\u1ea7u t\u01b0 n\u00e0o ph\u00f9 h\u1ee3p cho ng\u01b0\u1eddi m\u1edbi v\u1edbi c\u1ed5 phi\u1ebfu RNA?","answer":"B\u1eaft \u0111\u1ea7u v\u1edbi s\u1ed1 v\u1ed1n nh\u1ecf, mua theo ph\u01b0\u01a1ng ph\u00e1p trung b\u00ecnh gi\u00e1, \u0111\u1eb7t c\u1ea3nh b\u00e1o gi\u00e1, \u0111a d\u1ea1ng th\u1eddi \u0111i\u1ec3m mua v\u00e0 duy tr\u00ec t\u1ea7m nh\u00ecn \u0111\u1ea7u t\u01b0 d\u00e0i h\u1ea1n t\u1eeb 3-5 n\u0103m."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>C\u00e1ch mua c\u1ed5 phi\u1ebfu Avidity Biosciences, Inc. (RNA) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Avidity Biosciences, Inc. (RNA)<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-avidity-biosciences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Avidity Biosciences, Inc. (RNA) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Avidity Biosciences, Inc. (RNA)\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-avidity-biosciences\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-24T13:50:22+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-avidity-biosciences\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-avidity-biosciences\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Avidity Biosciences, Inc. (RNA) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Avidity Biosciences, Inc. (RNA)\",\"datePublished\":\"2025-08-24T13:50:22+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-avidity-biosciences\/\"},\"wordCount\":23,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-avidity-biosciences\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"vt-VT\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-avidity-biosciences\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-avidity-biosciences\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-avidity-biosciences\/\",\"name\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Avidity Biosciences, Inc. (RNA) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Avidity Biosciences, Inc. (RNA)\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-avidity-biosciences\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-avidity-biosciences\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp\",\"datePublished\":\"2025-08-24T13:50:22+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-avidity-biosciences\/#breadcrumb\"},\"inLanguage\":\"vt-VT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-avidity-biosciences\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"vt-VT\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-avidity-biosciences\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp\",\"width\":1024,\"height\":576},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-avidity-biosciences\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/vt\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Avidity Biosciences, Inc. (RNA) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Avidity Biosciences, Inc. (RNA)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/vt\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"vt-VT\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"vt-VT\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Avidity Biosciences, Inc. (RNA) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Avidity Biosciences, Inc. (RNA)","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-avidity-biosciences\/","og_locale":"en_US","og_type":"article","og_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Avidity Biosciences, Inc. (RNA) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Avidity Biosciences, Inc. (RNA)","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-avidity-biosciences\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-24T13:50:22+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-avidity-biosciences\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-avidity-biosciences\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Avidity Biosciences, Inc. (RNA) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Avidity Biosciences, Inc. (RNA)","datePublished":"2025-08-24T13:50:22+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-avidity-biosciences\/"},"wordCount":23,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-avidity-biosciences\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"vt-VT","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-avidity-biosciences\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-avidity-biosciences\/","url":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-avidity-biosciences\/","name":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Avidity Biosciences, Inc. (RNA) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Avidity Biosciences, Inc. (RNA)","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-avidity-biosciences\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-avidity-biosciences\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp","datePublished":"2025-08-24T13:50:22+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-avidity-biosciences\/#breadcrumb"},"inLanguage":"vt-VT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-avidity-biosciences\/"]}]},{"@type":"ImageObject","inLanguage":"vt-VT","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-avidity-biosciences\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals4.webp","width":1024,"height":576},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-avidity-biosciences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/vt\/"},{"@type":"ListItem","position":2,"name":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Avidity Biosciences, Inc. (RNA) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Avidity Biosciences, Inc. (RNA)"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/vt\/#website","url":"https:\/\/pocketoption.com\/blog\/vt\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/vt\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"vt-VT"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"vt-VT","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/vt\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"vt_VT","wpml_translations":{"pt_AA":{"locale":"pt_AA","id":344770,"slug":"how-to-buy-avidity-biosciences","post_title":"Como comprar a\u00e7\u00f5es da Avidity Biosciences, Inc. (RNA) - Investimento em a\u00e7\u00f5es da Avidity Biosciences, Inc. (RNA)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-avidity-biosciences\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts\/344766","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/comments?post=344766"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts\/344766\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/media\/334018"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/media?parent=344766"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/categories?post=344766"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/tags?post=344766"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}